Results 201 to 210 of about 56,016 (275)

Severe malaria treatment with rectal artesunate and artemisinin-based combination therapy in remote settings: an effectiveness-implementation hybrid type 3 study protocol (SEMA ReACT). [PDF]

Malar J
Hachizovu S, Manyando C, Nambozi M, Khondowe S, Hamainza B, Mukumbuta D, Rietveld H, Mukomena Sompwe E, Kikunda G, Muhindo-Mavoko H, Luzolo Khote F, Kanyamukenge D, Bastiaens H, Kakudji A, Maseko T, Makenga G, Baraka V, Mutombo A, Duparc S, Van Geertruyden JP.   +19 more
europepmc   +1 more source

Additive effects of GLY-200 (oral pharmacologic duodenal exclusion therapy) and GLP-1R agonist in obesity management. [PDF]

Mol Metab
Carlson TL, Fineman M, Kernodle S, Hutch CR, Bryant C, Colbert K, Seeley RJ, Nimgaonkar A.   +7 more
europepmc   +1 more source

Mandal, Sema

, 2019
Mandal, Sema
core  

Semaglutide promotes bone marrow-derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial. [PDF]

Eur Heart J
Park B, Dennis F, He AZ, Krishnaraj A, Bakbak E, Dennis CJ, Pan Y, Misner E, Thayanithy V, Lambotharan B, Lambotharan V, Lambotharan A, Mazer CD, Quan A, Teoh H, Hess DA, Verma S.   +16 more
europepmc   +1 more source

Multi-pathway-driven hepatic protection: Semaglutide combined with HIIT counteracts diabetic liver injury in db/db mice. [PDF]

J Diabetes Investig
Yu W, Liu Y, Le S, Xiao Y, Chen X, Wang J, Gao F.   +6 more
europepmc   +1 more source

Bariatric Surgery in the Era of GLP1RA: A Narrative Review. [PDF]

Adv Ther
Muhundan M, Dash S.
europepmc   +1 more source

Sema

, 2021
Sema şiirinden oluşan ...
Haspolat, Yusuf Kenan
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study)

Diabetes, obesity and metabolism, 2023
To investigate the effects of switching from liraglutide or dulaglutide to once‐weekly semaglutide on glycaemic control and treatment satisfaction in patients with type 2 diabetes.
Yuka Takahashi, H. Nomoto, H. Yokoyama, Yoshinari Takano, S. Nagai, A. Tsuzuki, K. Cho, A. Miya, H. Kameda, J. Takeuchi, Shinji Taneda, Y. Kurihara, T. Atsumi, A. Nakamura, H. Miyoshi   +14 more
semanticscholar   +1 more source

Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 2 study)

Diabetes, obesity and metabolism, 2023
To assess whether oral semaglutide provides better glycaemic control, compared with dipeptidyl peptidase‐4 inhibitor (DPP‐4i) continuation, in people with type 2 diabetes.
Shoichi Furusawa, H. Nomoto, Hiroki Yokoyama, Yuka Suzuki, A. Tsuzuki, Kiyohiko Takahashi, A. Miya, H. Kameda, K. Cho, J. Takeuchi, S. Nagai, Shinji Taneda, Y. Kurihara, A. Nakamura, Tatsuya Atsumi   +14 more
semanticscholar   +1 more source

Kedudukan SEMA Dalam Sistem Hierarki Perundang-Undangan Di Indonesia

ELQONUN: Jurnal Hukum Ketatanegaraan, 2023
Kedudukan Sema dalam sistem hierarki perundang-undangan di Indonesia yang diterapkan dalam putusan perkara tindak pidana narkotika Pengadilan Negeri Lahat yang penulis pegang sebagai Penuntut Umum.
Hendra Catur Putra
semanticscholar   +1 more source